Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 7, 2010
Stable overexpression of pregnane X receptor in HepG2 cells increases its potential for bioartificial liver applicationGeert A A Nibourg, Maarten T Huisman, Tessa V van der Hoeven, et al.
Biotechnology and Bioengineering|June 26, 2012
Perfusion flow rate substantially contributes to the performance of the HepaRG-AMC-bioartificial liverGeert A A Nibourg, Justin D Boer, Tessa V van der Hoeven, et al.
Molecular and Cellular Biology|January 16, 2008
The absence of Ser389 phosphorylation in p53 affects the basal gene expression level of many p53-dependent genes and alters the biphasic response to UV exposure in mouse embryonic fibroblastsWendy Bruins, Oskar Bruning, Martijs J Jonker, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 8, 2013
Effects of acute-liver-failure-plasma exposure on hepatic functionality of HepaRG-AMC-bioartificial liverGeert A A Nibourg, Ruurdtje Hoekstra, Tessa V van der Hoeven, et al.
The International Journal of Biochemistry & Cell Biology|June 18, 2013
Increased hepatic functionality of the human hepatoma cell line HepaRG cultured in the AMC bioreactorGeert A A Nibourg, Ruurdtje Hoekstra, Tessa V van der Hoeven, et al.
Artificial Organs|November 17, 2007
Enhanced oxygen availability improves liver-specific functions of the AMC bioartificial liverPaul P C Poyck, Guy Mareels, Ruurdtje Hoekstra, et al.
The International Journal of Artificial Organs|October 16, 2012
The effect of rat acute-liver-failure plasma on HepaRG cellsRuurdtje Hoekstra, Geert A A Nibourg, Tessa V van der Hoeven, et al.
Carcinogenesis|August 22, 2009
Finding transcriptomics biomarkers for in vivo identification of (non-)genotoxic carcinogens using wild-type and Xpa/p53 mutant mouse modelsMartijs J Jonker, Oskar Bruning, Maarten van Iterson, et al.
The International Journal of Biochemistry & Cell Biology|July 6, 2011
The HepaRG cell line is suitable for bioartificial liver applicationRuurdtje Hoekstra, Geert A A Nibourg, Tessa V van der Hoeven, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 15, 2012
Phase 1 and phase 2 drug metabolism and bile acid production of HepaRG cells in a bioartificial liver in absence of dimethyl sulfoxideRuurdtje Hoekstra, Geert A A Nibourg, Tessa V van der Hoeven, et al.
Pageof 2